Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
21
NCT01783691
Safety, Pharmacokinetic, and Pharmacodynamic Study of NKTT120 in Adult Patients With Stable Sickle Cell Disease (SCD)
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 28, 2013
Completion: May 31, 2015